Current Edition


vTv Therapeutics shares soar on licensing tie-up with Chinese group Newsoara Biopharma

Newsoara will develop vTv Therapeutics’ HPP737 as a new treatment for chronic obstructive pulmonary disease vTv Therapeutics (NASDAQ:VTVT) has sold licensing rights to a rival …

Continue Reading →

Chinese biopharma firm to create 400 jobs in Dundalk

WuXi Biologics will invest €325m in company’s first site outside of China A major Chinese biopharmaceutical company is to create 400 jobs with a €325 …

Continue Reading →